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Summary
A role for Wnt signaling in melanocyte specification from neural crest is conserved across vertebrates, but
possible ongoing roles in melanocyte differentiation have received little attention. Using a systems biology
approach to investigate the gene regulatory network underlying stable melanocyte differentiation in zebrafish
highlighted a requirement for a positive-feedback loop involving the melanocyte master regulator Mitfa. Here,
we test the hypothesis that Wnt signaling contributes to that positive feedback. We show firstly that Wnt
signaling remains active in differentiating melanocytes and secondly that enhanced Wnt signaling drives
elevated transcription ofmitfa. We show that chemical activation of the Wnt signaling pathway at early stages of
melanocyte development enhances melanocyte specification as expected, but importantly that at later
(differentiation) stages, it results in altered melanocyte morphology, although melanisation is not obviously
affected. Downregulation of Wnt signaling also results in altered melanocyte morphology and organization. We
conclude that Wnt signaling plays a role in regulating ongoing aspects of melanocyte differentiation in zebrafish.
Introduction
Melanocytes are a key derivative of the neural crest, and
the mechanisms of melanocyte development are of major
interest from developmental and stem cell biology and
applied biology perspectives, with clear relevance to
understanding human pigmentary disease (Aoude et al.,
2015; Mort et al., 2015; Speeckaert et al., 2015; White
et al., 2011; Yamaguchi and Hearing, 2014). Melanocyte
specification from neural crest cells has been relatively
well studied and has illuminated the underlying mecha-
nisms of neurocristopathies like the Waardenburg syn-
dromes (Dutton et al., 2001; Elworthy et al., 2003; Lee
et al., 2000; Southard-Smith et al., 1998). Numerous
genes contributing to the differentiated melanocyte
phenotype have been described, but little is known of
how stable melanocyte differentiation is maintained,
although this is likely to be significant in understanding
melanoma where reversion to a more progenitor-like
state helps drive proliferation and invasiveness (Kaufman
Significance
Gene regulatory networks underlie all aspects of the development of specific cell types. While fate
specification mechanisms and key genes associated with differentiation are often well studied, mechanisms
leading to maintenance of the differentiated state are less well understood, yet they are crucial from a
disease perspective. Positive-feedback loops are predicted to be crucial to these maintenance mechanisms.
We predicted that such a feedback loop acting on mitfa would be crucial for melanocyte maintenance, and
provided evidence supporting this hypothesis. Here, we provide evidence for the first time that in zebrafish,
ongoing Wnt signaling is likely to contribute to this feedback loop.
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et al., 2016; White et al., 2011). Stability of differentiation
is likely to be an emergent property of the state of the gene
regulatory network (GRN) in differentiated melanocytes.
Studies in both mouse and zebrafish have shown that
melanocyte specification depends upon the expression in
neural crest cells of microphthalmia-related transcription
factor (Mitf; mitfa in zebrafish), which encodes a basic
helix-loop-helix transcription factor (Hodgkinson et al.,
1993; Lister et al., 1999; Opdecamp et al., 1997; Stein-
grimsson et al., 1994; Watanabe et al., 2002). Mitf/mitfa
functions as the master regulator of melanocyte devel-
opment as it controls all aspects of melanocyte cell
biology including melanocyte survival, proliferation, mor-
phology, and melanogenesis itself (Cheli et al., 2010;
Levy et al., 2006; Lister et al., 1999; Steingrimsson et al.,
2004). Transcriptional activation of Mitf/mitfa depends
upon Sox10, a transcription factor of the Sry-related HMG
domain type, shown to bind directly to the Mitf/mitfa
promoter (Dutton et al., 2001; Elworthy et al., 2003;
Herbarth et al., 1998; Hou et al., 2006; Kelsh, 2006;
Southard-Smith et al., 1998). In addition, Wnt signaling,
acting via Lef-1- and b-catenin-mediated regulation of
Mitf/mitfa transcription, is also required for melanocyte
specification (Dorsky et al., 1998, 2000; Dunn et al.,
2000; Hari et al., 2012; Jin et al., 2001; Lee et al., 2004;
Takeda et al., 2000). Thus, the combined actions of early
Wnt signaling and Sox10 drive expression of Mitf/Mitfa,
which acts as a central node in the melanocyte GRN,
activating numerous genes associated with all aspects of
melanocyte differentiation (Cheli et al., 2010). Impor-
tantly, work in zebrafish has shown that a majority of
neural crest cells express mitfa transiently, but only a
subset form melanocytes (Curran et al., 2010). Thus,
maintenance of mitfa expression in a subset of neural
crest cells is an important, but under-appreciated, aspect
of melanocyte development and, indeed, likely repre-
sents a crucial part of the molecular basis for melanocyte
fate commitment; cells in which mitfa expression is not
maintained adopt alternative neural crest fates.
As a first step in understanding how this GRN results in
stable maintenance of melanocyte differentiation, we
used a systems biology approach, taking advantage of the
zebrafish model to allow rapid iterative cycles of mathe-
matical modeling and biological testing of a core
melanocyte GRN (Greenhill et al., 2011). Three cycles of
this approach resulted in an expanded core network that
incorporated a number of hypothetical components for
which we also provided experimental support (Figure 1A;
Greenhill et al., 2011). One of these hypothetical compo-
nents was a predicted Factor Y that enabled stabilization
of melanocyte differentiation by contributing to a positive-
feedback loop regulating mitfa expression (Greenhill
et al., 2011). We showed that while initial expression of
mitfa is driven by Sox10, sox10 then was gradually lost
from differentiating melanocytes, being undetectable by
in situ hybridisation or whole-mount immunofluorescence
by c. 50 h post-fertilization (hpf). Importantly, we showed
that continuing sox10 expression is not required for
melanocyte differentiation and indeed, may even delay
this process. In the Greenhill study, we showed that
Mitfa itself contributed to maintenance of mitfa expres-
sion, but left the identity of other possible components of
the feedback loop unknown.
The canonical Wnt pathway functions via regulation of
nuclear b-catenin levels; Wnt protein binding to its
transmembrane receptor, Frizzled, displaces glycogen
synthase kinase-3b (GSK3b) from the destruction com-
plex, preventing degradation of b-catenin in the cyto-
plasm, and resulting in elevated b-catenin levels in the
nucleus where it functions as a transcriptional activator in
cooperation with a co-activator, Lef-1 (Barker, 2008;
Kofahl and Wolf, 2010). Canonical Wnt signaling drives
fate specification of melanocytes via Tcf/Lef binding to
mitfa regulatory elements (Dorsky et al., 1998, 2000;
Takeda et al., 2000; Jin et al., 2001; Hari et al., 2012;
Dunn et al., 2000; Lee et al., 2004) although the relevant
Frizzled receptor remains elusive (Nikaido et al., 2013). In
melanocyte fate specification, Wnt signaling functions in
conjunction with Sox10 to drive mitfa expression; in a
sox10 mutant, mitfa expression is not detectable and
melanocytes do not form (Dutton et al., 2001), suggest-
ing that Wnt signaling alone is insufficient to drive mitfa
expression.
Here, we explore two possible modes by which Wnt
signaling may also contribute to melanocyte mainte-
nance: (i) by ongoing action alongside Sox10 and (ii) in a
Mitfa-dependent manner as a component of Factor Y
(Figure 1A). We use a transgenic reporter line to show
that Wnt signaling is active in melanocytes throughout
both specification and differentiation phases. We then
use small molecule stimulation of Wnt signaling showing
first that it activates mitfa expression and is rate-limiting
for melanocyte fate specification. We then use this
approach to show that stimulating Wnt signaling during
melanocyte differentiation affects melanocyte morphol-
ogy and arrangement according to the timing of treat-
ment. These shape changes correlate with upregulation
of mitfa expression levels in melanocytes. These mitfa
expression changes are independent of Mitfa activity in
the specification and early differentiation phases, but
depend upon Mitfa activity during late differentiation.
Conversely, using a transgenic repressor of Wnt signal-
ing, we show that inhibition of Wnt signaling during
melanocyte differentiation stages also results in melano-
cyte shape changes. This is consistent with our proposal
that Wnt signaling contributes to a Mitfa-dependent
positive-feedback loop that maintains melanocyte differ-
entiation, in a manner consistent with our mathematical
model of the core melanocyte GRN.
Results
Firstly, we asked whether Wnt signaling was active in
melanocytes during differentiation. We examined
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embryos carrying the Tg(top:GFP) reporter in which
expression of a destabilised GFP (dGFP) is driven by a
promoter containing four consensus LEF1-responsive
elements (Dorsky et al., 1998, 2002; Korinek et al.,
1997; Van De Wetering et al., 1997). We scored a sample
of melanocytes from these fish throughout melanocyte
differentiation (30–72 hpf), using a combination of
immunofluorescent detection of dGFP and a low dose
of PTU to partially inhibit melanisation to increase sensi-
tivity. We readily detected the activation of dGFP in the
tectum as previously described (Figure 1I; Dorsky et al.,
2002). We also observed, for the first time, dGFP
expression in melanocytes throughout the time period
examined (Figure 1B–G). At early stages, the majority of
melanocytes (78.5%) had readily detectable dGFP
expression, indicating that most cells at this stage were
responding to a Wnt signal. At later stages, a significant
proportion of cells still showed detectable dGFP expres-
sion, although by 72 hpf, the proportion of cells was
substantially lower (9%), but this is likely to at least partly
reflect the difficulties of detection of weak fluorescence
in even partially melanised cells.
Having shown that Wnt signaling remains active in
melanocytes throughout their differentiation, we then
tested the hypothesis that this Wnt signaling in melano-
cytes might contribute to regulation of their
differentiation. We utilized a well-characterized GSK3b
inhibitor, Bromoindirubin-30-oxime (subsequently referred
to as BIO), that has been used to investigate the effects
of increased Wnt signaling in many model systems,
including mammalian cardiomyocyte cell culture, mela-
noma cells (B16-F0), normal human melanocyte (NHM)
cells, mouse embryonic stem cells, and zebrafish (Alexan-
der et al., 2014; Bellei et al., 2008, 2010; Kim et al., 2010;
Moro et al., 2012; Sineva and Pospelov, 2010; Tseng
et al., 2006). Consistent with its activation of Wnt
signaling in our treated embryos, BIO treatment through-
out a 15–40 hpf time window activated dGFP reporter
expression in Tg(top:GFP) fish, both in the tectum and in
the melanocytes (Figure 1K, L); importantly, this BIO
treatment did not result in gross alterations to embryonic
morphology.
Wnt signaling has been shown to drive melanocyte
specification from the neural crest in both mouse and
zebrafish (Dorsky et al., 1998; Hari et al., 2012). As a
further positive control for the efficacy of BIO treatment
in modifying Wnt signaling in our fish, we tested the
prediction that BIO treatment in the correct time window
would increase melanocyte specification, resulting in
elevated melanocyte numbers. We used a shorter treat-
ment phase, focused on 15–30 hpf (Figure 2A), the time
when melanocyte specification is thought to occur in the
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Figure 1. Ongoing Wnt signaling is detectable in differentiating melanocytes. (A) Diagram of working model for melanocyte core GRN (modified
from Greenhill et al., 2011). Note, two inputs from Wnt signaling on mitfa expression, one well-established role acting alongside Sox10 driving
melanocyte fate specification, and hypothetical role explored here as part of a positive-feedback loop also involving Mitfa itself. (B–G) Wnt
signaling in differentiating melanocytes was assessed by scoring samples of melanocytes for detection of dGFP by immunofluorescence in Tg
(top:GFP) transgenic embryos from 30 to 72 hpf. GFP-positive melanocytes (arrows) are shown by immunofluorescence (B, D, F) and DIC (C, E, G)
to show melanin pigment. At each stage, 30 melanocytes in each of 15 embryos were assessed for GFP expression, in the dorsal head and
throughout the dorsal and lateral trunk; numbers show the percentage of melanocytes expressing GFP (mean  SD) at corresponding stages
(n = 450 per stage). (H) Schematic showing timing of BIO treatment used. (I–L) BIO treatment enhances activity of Tg(top:GFP) reporter. BIO
treatment from 15 to 40 hpf dramatically enhances dGFP expression (red arrows) in the tectum of treated (K) compared with mock-treated
controls (I) and also increases dGFP signal in melanocytes of Tg(top:GFP) embryos [BIO-treated (L) compared with mock-treated control (J)]. All
images, lateral views using confocal microscopy. EM, embryo medium; e: eye; T: tectum. Scale bars: (B–G) 10 lm; (I–L) 100 lm.
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head and trunk. As expected, this treatment resulted in
significantly increased melanocyte number in the head of
treated embryos compared with controls (Figure 2B–F).
Taking advantage of the developmental gradient in these
embryos, we examined the trunk and tail region of
embryos fixed at the same stage to examine whether
elevated melanocyte numbers might be preceded by
elevated mitfa expression in melanocyte progenitors
(premigratory neural crest cells). Consistent with our
current working model of the melanocyte GRN, BIO-
treated embryos showed increased mitfa expression in
premigratory neural crest cells compared with mock-
treated controls (Figure 2G–J). Our data suggest that the
increased mitfa reflects increases in both the levels of
mitfa expression within a cell and the number of mitfa-
expressing cells (Figure 2D, E; compared with B, C),
consistent with the predicted increase in melanocyte fate
specification. Taken together, our data support the
conclusion that BIO treatment in a 15–30 hpf time
window results in elevated melanocyte specification
through increased mitfa expression after activation of
Wnt signaling. In addition, BIO-treated embryos show a
reduction in ventrally positionedmitfa+ cells, suggesting a
transient inhibition of melanoblast migration.
Having validated BIO treatment as an effective method
for elevating Wnt signaling, we then addressed our
hypothesis that ongoing Wnt signaling might be impor-
tant for melanocyte differentiation and maintenance. In
this study, we divided melanocyte differentiation into
early and late phases according to sox10 expression
(Figure 3A). In the early differentiation phase (24–48 hpf),
sox10 expression in melanocytes is decreasing but still
detectable by WISH and immunofluorescence, whereas
in the late differentiation phase (48–72 hpf), sox10 is not
detectable by WISH or immunofluorescence (Greenhill
et al., 2011). We analyzed the consequences of boosting
Wnt signaling via BIO treatment throughout the entire
differentiation phase (24–72 hpf) and during each of the
early and late phases of differentiation. Firstly, we tested
whether these treatments gave any effects in terms of
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Figure 2. Elevated Wnt signaling in melanocyte specification time window increased numbers of melanocytes. (A) Schematic showing timing of
BIO treatment or control mock treatment (DMSO alone) used. (B–E) Lateral views of the trunk of live 30 hpf zebrafish embryos showing
melanocytes (red arrows); note, increased number in both anterior (D) and posterior trunk (E) of embryos treated with 5 lM BIO compared with
control DMSO-treated embryos (B, C, respectively). (F) Quantitation of increased melanocyte number in heads of BIO-treated embryos
(mean  SD; control, 13  2.1; BIO, 32  5.3, P < 106) (n = 20; *** indicates significant difference between treated and mock treated;
unpaired, one-tailed t test). (G–J). Lateral views of posterior trunk (G, I) and close-up of anterior tail (H, J) of 30 hpf zebrafish embryo in situ
hybridisations to show mitfa expression in embryos treated with BIO (I, J) or DMSO control (G, H). In the DMSO control embryos (G, H),
discontinuous mitfa expression is observed in the dorsal region (blue arrows show discontinuities of the signal), whereas in the BIO-treated
embryos (I, J), mitfa expression is continuous throughout the dorsal region (red arrows). Images show representative phenotypes (n = 20 per
treatment). Scale bar: 100 lm.
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melanocyte cell number, focusing on the head region. In
contrast to 15–30 hpf treatment, no increase in melano-
cyte number was observed after BIO treatment from 24
to 48 hpf (control, mean  SD = 23.9  2.01; BIO,
mean  SD = 23.1  4.03, P = 0.443), suggesting that
Wnt-dependent melanocyte fate specification is com-
plete in the head region by 24 hpf.
Next, we assessed melanocyte differentiation, looking
for any changes associated with BIO treatment during the
differentiation phases. In these BIO treatments, we saw
distinctive morphological changes to melanocytes, but
interestingly, the phenotype differed depending upon the
period of BIO treatment. Embryos treated during the early
differentiation time window and examined at 48 hpf
displayed a dramatic increase in cell dendricity (Figure 3C,
E) compared with mock-treated controls (Figure 3B, D).
To quantitate this striking phenotype, we used IMAGEJ
software (Schneider et al., 2012) to estimate the round-
ness parameter, an established formula relating cell
perimeter and cell area (Figure 3F). We found BIO
treatment resulted in a significant increase in cell
dendricity compared with mock-treated controls
[mean  SD: control, 2.44  0.43; BIO, 4.25  1.68,
P = 0.004 (unpaired, one-tailed t test)]. Importantly, this
change in cell shape at 72 hpf was not observed in 24–
72 hpf (Figure 3G–N) or 48–72 hpf treatments (data not
shown) suggesting that this aspect of cell differentiation
was only sensitive to Wnt signaling for a period between
24 and 48 hpf, and that the shape changes were only
transient. Indeed, where embryos treated in this way
were examined at both 48 and 72 hpf, we saw a clear
dendricity phenotype at 48 hpf, but this had recovered by
72 hpf (data not shown). In contrast, embryos treated
with BIO from 24 to 72 hpf showed disorganized
melanocytes in the dorsal head; cells were more dis-
persed, disrupting the ‘U’- or ‘O’-shaped organization
typical of control embryos (Figure 3G–J). Treatment
during the late differentiation phase alone (i.e., from 48
to 72 hpf) resulted in a similar phenotype (data not
shown). A multidistance spatial cluster analysis using
Ripley’s K Function (Ripley, 1977) was performed using
SPATSTAT package in R (Baddeley and Turner, 2005) to
quantify the decrease in patterned organization of
melanocytes in the dorsal head using comparable pic-
tures of DMSO- and BIO-treated fish (Figure S1). We
found that the Ripley’s K function confirms the non-
random organization of melanocytes in dorsal heads of
DMSO-treated embryos (scale of analysis of r = 35
pixels). Indeed, at this scale of analysis, for eight of the
ten embryos, the observed K value was smaller than the
expected K value if cells were randomly spread (Fig-
ure S1A–C, E, G, H, J). The result of the Ripley’s K
analysis performed on BIO-treated embryos showed that,
at r = 35, the observed K values were found within the
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Figure 3. Elevated Wnt signaling in melanocyte differentiation time window alters melanocyte morphology. (A) Schematic of melanocyte
differentiation BIO treatment time windows. (B–E) Activation of Wnt signaling in early differentiation period (24–48 hpf) increases melanocyte
dendricity and dispersion. Lateral view at 48 hpf of head of live embryos treated with control DMSO (B) or BIO (C) from 24 to 48 hpf. Panels D and
E show enlargements of head melanocytes from embryos in B and C, respectively. (F) Quantitation of dendricity: the cell roundness parameter
was calculated for each melanocyte as R = P2 ⁄ 4∏A, where A is the cell area and P the cell perimeter, and 20 cells were investigated (n = 20) in
10 different embryos for each condition. A score of R = 1.0 represents a perfectly round melanocyte; increased R values represent increased
dendricity. Control, R = 2.44  0.43, BIO R = 4.25  1.68, P = 0.004, t test result, P-value < 0.01 (**). (G–J) Elevated Wnt signaling throughout
full differentiation or during late differentiation window only affects melanocyte organization. Red line in G indicates the dorsal head melanophores
which usually approximate an O- or U-shaped pattern, although often with extra branches as in this specific example. Dorsolateral view at 72 hpf
of heads of live embryos treated with control DMSO (G, I, K, M) or BIO (H, J, L, N) from 24 to 72 hpf shown. Note that embryos treated in only late
differentiation window (48–72 hpf) show equivalent phenotype (data not shown). Embryos shown are representative of samples examined
(n = 160 zebrafish embryos for each treatment). Scale bars: 100 lm (B, D, G, I).
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lower confidence envelop (in the gray area) of the graph
meaning that cells were randomly spread in 90% of the
cases in nine of ten embryos (Figure S1K–T). Conversely,
80% of the DMSO population shows a non-random cell
organization and 10% of the BIO-treated population
shows a non-random cell organization. A z-test was then
performed to compare the two populations for cellular
spatial organization using the results of this analysis (at
r = 35, comparing ‘random’ or ‘not-random’); the two
populations were significantly different for this parameter
(P-value = 0.00164, P < 0.01). We conclude that treating
embryos with BIO in the early phase of differentiation led
to changes in cell shape, whereas ongoing BIO treatment
resulted in changed melanocyte arrangement.
Our working model of the melanocyte GRN predicted
thatmitfa transcription would be increased in response to
activation of Wnt signaling. Using quantitative RT-qPCR,
we saw a BIO-dependent increase in mitfa transcript
levels after each of the treatment windows (Figure 4A).
mitfa expression was increased by around fivefold in
embryos treated from both 24 to 48 hpf and 48 to 72 hpf
whereas a ninefold increase was observed in embryos
treated from 24 to 72 hpf. Combining these data with the
melanocyte phenotype changes observed above, we
suggest that elevated mitfa expression can have distinct
effects depending upon whether cells are in a plastic
progenitor state (fate specification phase) or are
committed to the melanocyte fate (differentiation phase).
Our model (Figure 1A) proposes two modes for Wnt
action, one in conjunction with Sox10 and thus unlikely to
be significant beyond 48 hpf when sox10 expression in
melanocytes is lost (Greenhill et al., 2011), and one as
Factor Y, where it would function as part of a positive-
feedback loop with Mitfa, and thus would be dependent
Figure 4. Positive feedback between Wnt signaling and Mitfa during late differentiation phase of melanocyte development. (A) Quantitation of
mitfa expression by RT-qPCR showing significantly increased levels in BIO-treated embryos compared with untreated controls; data are
expressed as percentage of mock-treated controls [control mitfa level = 100% transcripts (red line on graph)]. Gene expression was investigated
in 10 samples consisting of the trunk and tail of 50 embryos for each condition and in triplicate, after normalization to the stable expression of a
reference house-keeping gene, gapdh. All treatments caused significant increase of mitfa expression [t test, two-tailed: 24–48 hpf, 535  7.1
(P = 0.00087); 48–72 hpf, 496  9.8 (P = 0.0085); 24–72 hpf, 872  32.1 (P = 0.000092). ***P-value < 0.001]. (B–G) Activating Wnt signaling
after 48 hpf does not affect mitfa expression in mitfaw2 mutant embryos during melanocyte differentiation. Lateral views of trunk showing in situ
hybridisation for mitfa expression in mitfa mutant fish. mitfa mutant embryos treated with BIO in the melanocyte specification phase (15–30 hpf)
(C) showed increasedmitfa expression (purple) compared to DMSO-treated embryos (B). Similarly,mitfa mutant embryos treated with BIO in the
melanocyte early differentiation phase (24–48 hpf) (E) showed increased mitfa expression in tail dorsal stripe melanocytes compared to DMSO-
treated embryos (D). In contrast, mitfamutant embryos treated with BIO throughout the late melanocyte differentiation phase (48–72 hpf) (G) did
not show increased mitfa expression compared to DMSO-treated embryos (F) at 72 hpf; 40 zebrafish embryos were investigated for each
condition; BIO-treated and matched control embryos were processed for in situ hybridisation in parallel and under identical conditions. (H)
Quantitation of mitfa expression by RT-qPCR showing significantly increased levels in BIO-treated embryos at 30 hpf compared with untreated
controls but not at 48 hpf nor at 72 hpf; data are expressed as percentage of mock-treated controls [control mitfa level = 100% transcripts (red
line on graph)]. Gene expression was investigated in triplicate, after normalization to the stable expression of a reference housekeeping gene,
gapdh. Only 15–30 hpf treatment caused significant increase of mitfa expression [t test, two-tailed: 15–30 hpf, 160.39  7.27 (P = 0.0020); 24–
48 hpf, 108.15  7.9 (P = 0.0675); 24–72 hpf, 104.6  8.36 (P = 0.544); 24–72 hpf, 86.14  8.96 (P = 0.0831). **P-value < 0.01]. (I) The effect
of the three BIO treatments applied in the 24–48, 48–72, and 24–72 hpf time windows is shown on Mitfa only as compared to the case of no
treatment. The 24–48 and 48–72 hpf BIO treatments induce an approximately equal increase of Mitfa as measured at the end of the treatment. (J)
Revised GRN model. Scale bars: 100 lm.
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upon active Mitfa. To test whether the increase in mitfa
expression observed in BIO-treated embryos was (i)
specific for melanocytes and (ii) Mitfa dependent, we
used whole-mount in situ hybridisation and RT-qPCR to
assess mitfa expression in BIO-treated mitfaw2 mutants
(Figure 4B–H). The mitfaw2 mutant is a functional null
allele, but expression ofmitfa transcripts can be assessed
by in situ hybridisation (Johnson et al., 2011). In all cases,
mitfa expression was restricted to cells with the mor-
phology and distribution consistent with them being
neural crest or melanocyte lineage cells, consistent with
a cell-autonomous response. Importantly, BIO treatment
of mitfaw2 mutants in a 15–30 hpf window (i.e., during
cell specification, when sox10 is relatively strongly
expressed in the melanocyte lineage) resulted in
increasedmitfa expression (Figure 4H), most clearly seen
as increased numbers of cells expressing relatively high
levels of mitfa, at 30 hpf compared with mock-treated
embryos (Figure 4B, C). A 24–48 hpf BIO treatment,
assessed at 48 hpf, showed an elevated level of mitfa
expression in mitfaw2 mutants, at least in the dorsal tail
(Figure 4D, E). In contrast, BIO treatment in a 24–72 (data
not shown) or 48–72 hpf window (Figure 4F, G),
assessed at 72 hpf, did not show elevated mitfa tran-
scription in these mitfaw2 mutants (Figure 4H), suggest-
ing that the Wnt-mediated effect is Mitfa dependent.
Quantitation of mitfa expression levels using RT-qPCR
confirmed the significant increase in mitfa expression
after 15–30 hpf treatment even in mitfaw2 mutants, and
the absence of a significant response after the 24–72 and
48–72 hpf time windows. Our quantitative assay did not
detect the change after a 24–48 hpf time window:
although consistently detectable by the semi-quantitative
whole-mount in situ hybridisation technique, which has
the advantage of assessing individual cells in different
spatial domains, this signal is apparently masked by the
general signal coming from the head and trunk. We
conclude that Wnt inputs on mitfa expression act initially
through the Sox10-dependent mechanism, but then
switch to functioning through a Sox10-independent,
Mitfa-dependent positive-feedback loop.
As a complement to these gain-of-function studies,
we tested the effects of loss of Wnt signaling activity
during melanocyte differentiation using a conditional
activation of the dominant-negative T-cell Factor 3
(Tcf3) in transgenic zebrafish carrying Tg(hsp70l:tcf3-
deltaC-GFP) (Martin and Kimelman, 2012). As before, we
tested the functionality of our experimental system by
inducing heat shock during the specification phase of
melanocyte development, from 15 to 28 hpf, and
assessing first activation of GFP fluorescence and
expression of Wnt signaling targets such as mitfa, by
RT-qPCR. Both activation of GFP and downregulation of
mitfa expression were observed after heat shock (data
not shown). To assess the requirement for ongoing Wnt
signaling in melanocyte differentiation, we heat-shocked
embryos at each of four timepoints, 29, 36, 48, and
62 hpf, before assessing melanocyte phenotypes in the
dorsal head at 73 hpf. Two populations of embryos could
be distinguished by the level of activation of GFP, one
where embryos showed strong GFP fluorescence and
the second population showing weak GFP fluorescence;
we note that in almost all cases, melanocytes were
abundant, indicating that survival of melanocytes was
usually not affected, although in a subset of the fish
exhibiting strong GFP, melanocyte number was visibly
reduced. In the first population (strong inhibition of Wnt
signaling), melanocyte melanisation, apparent morphol-
ogy, and patterning were all abnormal, but as the gross
anatomy of the embryos was also affected, these
melanocyte phenotypes were not quantitated. However,
we noticed that a subset of melanocytes in each fish
was abnormally rounded, melanisation was always
reduced, and these cells were abnormally patterned
(Figure S2). In the second population (weak inhibition of
Wnt signaling), melanocyte morphology was more
normal, but their patterning was modified compared to
non-heat-shocked siblings (Figure 5). We observed
enhanced clustering of melanocytes, particularly in the
posterior region of the dorsal head (Figure 5B, D, F, H,
blue arrowheads). Again, we used multidistance spatial
cluster analysis using Ripley’s K Function (Ripley, 1977)
to quantify the change in patterned organization of
melanocytes in the dorsal head using comparable
pictures (Figure S3). This analysis showed that whereas
90% of the non-heat-shocked Tg(hsp70l:tcf3-deltaC-GFP)
embryos showed ‘non-random’ pattern, 70% of the
heat-shocked Tg(hsp70l:tcf3-deltaC-GFP) embryos
showed loss of organization (‘random’ cell organization
—the combination of the clustered melanocytes in the
posterior head and the unclustered melanocytes in the
anterior head are together scored by the algorithm as
more randomly organized using this scale of analysis)
(scale of analysis of r = 50 pixels). A z-test comparing
the two populations for cellular spatial organization using
the results of this analysis (at r = 50, comparing ‘ran-
dom’ or ‘not-random’) showed they were significantly
different for this parameter (P-value = 0.00244,
P < 0.01). We conclude that inactivating Wnt signaling
during melanocyte differentiation in Tg(hsp70l:tcf3-del-
taC-GFP) using heat shock led to significantly increased
clustering of melanocytes in the posterior part of the
dorsal head. We note that this loss-of-function pheno-
type is complementary to the gain-of-function phenotype
using drug treatment, suggesting that Wnt signaling has
a consistent impact on melanocyte differentiation in
zebrafish in vivo.
We used the mathematical modeling approach we
developed before (Greenhill et al., 2011) to assess the
effects of including Wnt signaling (Figure S4A). We
incorporated Wnt signaling in both fate specification and
differentiation phases by assuming Wnt expression to
activate b-catenin/Lef-1 (abbreviated as T), coupled in
turn with an AND gate to Sox10 during specification,
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and by another AND gate to Mitfa during commitment.
For such a highly migratory cell type, melanocyte fate
specification (in/near the dorsal neural tube) and
melanocyte differentiation (during dispersion and in
post-migratory locations) are usually anatomically dis-
tinct and, given the complexity of Wnt expression
patterns, thus are intuitively likely to involve distinct
Wnt family members. Thus, we postulated two inde-
pendent Wnt signals, one (WntA) acting in an early, but
transient, time window lasting to approximately 30 hpf,
and another (WntB) beginning at that latter timepoint
and extending throughout differentiation. We also
assumed a threshold level of T required to trigger a
response from the AND gate between Sox10 and T
(Figure S4A, B), and a threshold level of Mitfa to avoid
accidental activation of the Mitfa feedback loop (see
Greenhill et al., 2011). As in Greenhill et al. (2011), one
of the key outcomes used to judge the appropriateness
of the subsequent simulations was that mitfa expres-
sion initially rose, and then was maintained at a
substantial level. Indeed, under normal conditions, our
revised model results in expression profiles comparable
to those of the original Greenhill Model C (Greenhill
et al., 2011). Moreover, modeling the effects of mutat-
ing the two Wnt signals independently behave as
expected intuitively (Figure S4C, D). In particular, in
the absence of the first Wnt signal, WntA, melanocyte
specification fails and mitfa expression remains absent
(Figure S4C); likewise, in the absence of the second
Wnt signal, WntB, mitfa expression peaks transiently
before disappearing rapidly, so that maintenance of the
differentiated state fails (Figure S4D). Currently, Wnt8
has been proposed as an inducer of neural crest in
zebrafish (Lewis et al., 2004), but knowledge of the Wnt
signals underlying melanocyte development in fish is
very limited, although Wnt8 has been shown not to be
critical (Dorsky et al., 1998; Lewis et al., 2004); a
testable prediction of our modeling is that two distinct
Wnt signals drive early melanocyte fate specification
versus later maintenance of differentiation.
We then assessed in silico the effect of increasing
Wnt signaling strength in each of the specification and
(early, late, and full) differentiation phases. We did this
by modifying the amount of WntA and WntB driving
expression of T, and simulating accordingly the GRN
response. We modeled the derepression of the Wnt
signal due to the action of the BIO treatment as a linear
increase in time of WntA/B. As a consequence, we
expected the elevated expression of mitfa induced by
BIO to be proportional to the duration of the BIO
treatment. Indeed, by choosing parameter values com-
patible with values in the literature (see Methods), the
simulations show a relative increase of Mitfa expression
in response to BIO compatible with the experimental
data (Figure 2). In particular, we show that when BIO is
applied for the same amount of time (namely in the time
windows 24–48 and 48–72 hpf), the increase in mitfa is
approximately the same. In contrast, when BIO is
applied between 24 and 72 hpf, our simulations show
a larger mitfa increase, roughly comparable with the
observed linear dependency. Thus, our revised model
with its more precise delineation of the roles of Wnt
signals at different phases in melanocyte development
continues to correspond well to the key experimental
observations in vivo.
Our observation that elevated Wnt signaling in the
specification phase results in more cells becoming
melanocytes is readily accounted for by the model
through the threshold on T. The likelihood of a mitfa-
expressing cell maintaining mitfa expression and thus
differentiating into a melanocyte depends on T being
above this threshold in the specification phase. In a
population of cells, we expect stochastic variations in the
levels of WntA (and hence T) will result in this condition
A
B
C
D
E
F
G
H
Figure 5. Inactivation of Wnt signaling during melanocyte differentiation enhances melanocyte clustering in posterior dorsal head. Tg(hsp70l:tcf3-
deltaC-GFP) embryos were heat-shocked at 29, 36, 48, and 62 hpf and observed at 73 hpf (B, D, F, H) and compared to control non-heat-shocked
transgenic Tg(hsp70l:tcf3-deltaC-GFP) (A, C, E, G). Note the enhanced clustering of melanocytes in the posterior part of the dorsal head in treated
embryos (blue arrowheads); the normal distribution in this area in untreated controls is indicated by red arrows. Heat shock activation of Wnt
inhibition consistently resulted in smaller heads and eyes. Scale bars: 100 lm.
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not being satisfied in some cells. If BIO is applied early, T
levels are enhanced, and therefore during the specifica-
tion phase (i.e., prior to commitment), the proportion of
cells proceeding successfully toward the melanocyte
state is predicted to increase. In contrast, if BIO is only
applied later, T levels during the earlier specification
window are unaffected, so no change in the final number
of melanocytes is predicted, in agreement with our
experimental data.
Discussion
We conclude that in addition to the established role for
Wnt signaling in melanocyte specification from the
neural crest, Wnt signaling has an ongoing influence on
melanocyte differentiation at least until 72 hpf. Using a
transgenic reporter strain, we demonstrated that Wnt
signaling remained detectable in differentiated melano-
cytes until 72 hpf at least. We then used BIO to assess
the effects of increased Wnt signaling on melanocyte
development in zebrafish embryos, showing that such
treatment resulted in elevated mitfa expression in the
neural crest and melanocyte lineage cells. Interestingly,
we observed defects in melanocyte morphology with
an increase in cell dendricity at 48 hpf and altered cell
organization at 72 hpf. We complemented these gain-
of-function studies with a loss-of-function approach,
using a conditional dominant-negative transgenic line to
inhibit Wnt signaling activity during melanocyte differ-
entiation phases. Importantly, our data showed that this
resulted changes in melanocyte morphology (when
dnTcf3 strongly expressed), resulting for example in
enhanced clustering of melanocytes in the posterior
head. This study demonstrates for the first time a
function for Wnt signaling in zebrafish melanocytes,
beyond the well-known role in melanocyte fate speci-
fication, showing that it is important for multiple
aspects of melanocyte differentiation. We note that
our data indicate that the mode of Wnt signaling input
changes from a Mitfa-independent/Sox10-dependent
early role to a Mitfa-dependent/Sox10-independent later
role, suggesting that Wnt signaling at late stages
becomes incorporated into the melanocyte maintenance
(Factor Y) role postulated in our earlier work. We have
revised our working model of the core GRN of
melanocyte development in zebrafish to incorporate
these new data (Figure 4J). It is likely that Wnt
signaling has a similar role in mammalian melanocytes
as GSK3b inhibition results in upregulation of MITF
expression and differentiation in normal human mela-
nocytes, at least in cell culture (Bellei et al., 2008).
Although we show here that Wnt signaling continues to
influence melanocyte differentiation, our gain-of-function
experiments do not cause obvious effects on melanisa-
tion. However, we note that our modeling data (Fig-
ure S4E, F) indicate that this may be quantitatively
relatively subtle (e.g., for dct in curves shown), so our
failure to detect such an effect in vivo may be simply due
to lack of sensitivity in our assay. A study of normal
human melanocytes in tissue culture showed that GSK3b
inhibition stimulated melanogenesis through activation of
MITF (Bellei et al., 2008). In contrast, in our loss-of-
function experiments, those embryos showing highest
levels of GFP and in which Wnt signaling was presumably
most inhibited showed a pronounced reduction in both
melanin levels and defects in apparent cell morphology.
Thus, it seems that Wnt signaling is important for all
aspects of melanocyte differentiation, consistent with its
effects on expression of mitfa.
The role for Wnt/b-catenin signaling in melanocyte
specification through induction of Mitf expression is
conserved in fish and mammals (Dorsky et al., 2000;
Takeda et al., 2000). Our work showing that inhibition of
GSK3-b using BIO stimulates melanoblast specification
(mitfa expression) adds further support to this conclu-
sion. Importantly, no increase in melanocyte cell number
in the dorsal head was observed after 24–72 hpf
treatments suggesting that melanocyte specification
from neural crest cells does not extend much beyond
24 hpf. Furthermore, our time window studies showed
that treatment from 15 to 30 hpf was sufficient to
generate elevated numbers of head melanocytes that
persist until at least 72 hpf, whereas treatment in a 24–
48 hpf window did not. These data indicate, for the first
time to our knowledge, that commitment to the
melanocyte fate in zebrafish (at least for melanocytes
in the head region that arise in the embryo) has occurred
by c. 30 hpf. As explained above, melanocyte specifica-
tion reflects maintenance of mitfa expression in NCCs,
so our data suggest that this process is limited by Wnt
signaling.
Our data demonstrate intriguing Wnt-dependent
effects on melanocyte morphology and organization.
An in vitro study of normal human epidermal melano-
cytes demonstrated that increased and decreased levels
of active b-catenin resulted in increased and decreased
cell dendricity, respectively (Kim et al., 2010). They
further showed that this resulted from activation of
distinct downstream modulators, PKCf and PKCd,
respectively (Kim et al., 2010). They showed that over-
expression of PKCf resulted in the decrease of protein
levels for Rac1 and Cdc42 and consequently a reduction
of dendrite formation in melanocytes, while overexpres-
sion of PKCd led to increase of Rac1 and Cdc42 and an
increase in melanocyte dendrites. We show here that
elevated Wnt signaling results in increased mitfa expres-
sion and increased dendricity, suggesting a causal link
between mitfa expression levels and cell shape. This
idea is strongly supported by earlier studies in Xenopus
embryos showing that increased X-mitfa expres-
sion resulted in increased melanocyte dendricity and
cell dispersal (Kawasaki et al., 2008; Kumasaka et al.,
2005). Further studies will be required to test whether
Wnt signaling in zebrafish causes increased melanocyte
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dendricity through a pathway of mitfa-dependent
activation of PKCd, elevated levels of activated Rac
and Cdc42, and consequent modifications of the actin
cytoskeleton.
In summary, our work defines two phases of Wnt
signaling involvement in zebrafish melanocyte develop-
ment in vivo, both of which are likely conserved in
mammals. Recent analysis showed that the two tran-
scription factors Tfap2a and Tfap2e are required for early
melanocyte differentiation, through both maintenance of
kit expression and another mechanism still to be defined
(Van Otterloo et al., 2010). It will be of interest to assess
whether these roles for Tfap2 factors extend to ongoing
maintenance of the differentiated state and, if so, the
extent to which Wnt signaling and Tfap2/Kit function are
integrated in this system.
Methods
Fish husbandry
Wild-type (AB) and transgenic Tg(-7.2sox10:EGFP) (Carney et al.,
2006) and Tg(top:GFP) (Dorsky et al., 2002) and mutant mitfaw2
(Lister et al., 1999) zebrafish, Danio rerio, were kept in the
aquarium at the University of Bath. Tg(hsp70l:tcf3-deltaC-GFP)
(=w26Tg) fish (Martin and Kimelman, 2012) were kept in the
facilities of the Department of Developmental and Cell Biology,
School of Biological Sciences at the University of California, Irvine.
Natural crosses were set up overnight and embryos collected in the
morning. Embryos were placed in embryo medium and grown at
28.5°C. They were staged according to Kimmel et al. (1995).
Where embryos were to be manipulated between laying and
hatching, we used Watchmakers’ No5 forceps to dechorionate the
embryos. Embryos older than 15 hpf which were to be manipulated
in any way were anaesthetised with Tricaine (ethyl 3-aminobenzo-
ate methanesulphonate, 4 g/l stock, final concentration approxi-
mately 0.2% v/v). Where appropriate, melanisation was inhibited
using PTU (1-phenyl-2-thiourea) from 24 hpf at a final concentration
of 0.0015% in embryo medium. All experiments complied with
institutional and national animal welfare laws, guidelines, and
policies. Procedures involving fish older than 5 dpf were under-
taken under license from the UK Home Office.
BIO (20Z,30E)-6-bromoindirubin-30-oxime) treatment
BIO (20Z,30E)-6-bromoindirubin-30-oxime): GSK3b inhibitor (Cal-
biochem; Merck Chemicals Ltd., Nottingham, UK) was stored as a
10 mM stock solution in DMSO. Ten wild-type or mitfaw2 mutant
embryos were placed in triplicate into 6-cm petri dishes containing
8 ml embryo medium. All embryos were dechorionated before
10 mM BIO (361550 GSK-3 Inhibitor IX, Calbiochem) in DMSO was
added to each experimental dish to a final concentration of 5 lM; an
equivalent volume of DMSO was added to the control dishes.
Embryos were incubated under standard conditions from 15 to 30, 24
to 48, 48 to 72, or 24 to 72 hpf.
Heat-shock experiment
Tg(hsp70l:tcf3-deltaC-GFP) transgenic embryos (Martin and Kimel-
man, 2012) were heat-shocked at 39°C for 12 min at four timepoints
(29, 36, 48, and 60 hpf) during melanocyte differentiation; after heat
shock, embryos were assessed for GFP expression and left to
develop at 28.8°C in incubator. Embryos were assessed for
melanocyte differentiation defects at 73 hpf.
Whole-mount in situ hybridisation
RNA in situ hybridisation was performed according to Thisse and
Thisse (2008) except probes were not hydrolyzed and embryos were
incubated at 68°C in hybridization steps. Probes used were sox10
(Dutton et al., 2001),mitfa (Lister et al., 1999), and xdh (Parichy et al.,
2000). (Plasmid and probe generated by T. Chipperfield and C. Nelson).
RNA extraction and cDNA synthesis
RNA was extracted from samples consisting of 50 whole embryos of
each condition using TRI REAGENT (Sigma-Aldrich, Irvine, UK,
T9424) according to manufacturer’s instructions and purified and
precipitated by phenol/chloroform/isoamylalcohol (25:24:1). The RNA
pellet was washed in 1 ml of 75% ETOH by inverting the tube gently.
A 1 ll sample was assessed for purity, integrity by gel electrophore-
sis, and concentration was measured spectrophotometrically. When
required, samples were stored at 80°C for not more than a month.
For experiment using WT embryos, first-strand cDNA was synthe-
sised using the Invitrogen First-strand cDNA synthesis kit with
Superscript III and oligodT (Promega, Southampton, UK), 0.5 ll
random hexamers (250 ng/ll) (Promega), 5 ll dNTPs (2 mM)
(Promega), and 7.5 ll RNA (1 lg of total RNA) were first mixed
and incubated for 5 min at 65°C and then at least 1 min at 4°C.
Secondly, 4 ll of 59 first-strand buffer (Invitrogen, Paisley, UK), 1 ll
of 5 mM DTT, 1 ll RNase out (Invitrogen), and 1 ll superscript III
(Invitrogen) RTase/Mll were added to the previous mix and left 5 min
at 25°C, 60 min at 50°C, 15 min at 70°C. Finally, samples were
diluted 1:5 and concentrations were measured spectrophotometri-
cally. For experiments using mitfaw2 mutant embryos, RNA extrac-
tion was performed by Direct-zolTM RNA MiniPrep (Zymo Research,
Cambridge, UK) and the iScriptTM Advanced cDNA Synthesis Kit (Bio-
Rad Laboratories Ltd., Watford, Hertfordshire, UK) was used for
reverse transcription of 1 lg RNA in 20 ll reaction according to
manufacturer’s protocol.
Real-time quantitative PCR
Real-time quantitative PCR was performed in triplicate using SYBR
Green I PCR Master Mix (Roche, West Sussex, UK) for WT embryos,
and a Lightcycler II machine (Roche) was used according to the
manufacturer’s instructions. For mitfaw2 mutant embryos, the Fast
SYBR Green Master Mix (Thermo Fisher, Paisley, UK) was used and
samples were run in triplicate using the StepOneTM System (Thermo
Fisher) according to manufacturer’s instructions. Standard curves for
both gapdh and mitfa primers demonstrated nearly 100% efficiency
(98.7% and 98.5%, correspondently). Primers were designed span-
ning an intron using PRIMER3 PLUS software (http://www.bioinformatic
s.nl/cgibin/primer3plus/primer3plus.cgi.). The following primers were
used:
gapdh: forward 50ACCAACTGCCTGGCTCCT30, reverse
50TACTTTGCCTACAGCCTTGG30;
mitfa: forward50CTGGACCATGTGGCAAGTTT30, reverse
50GAGGTTGTGGTTGTCCTTCT30.
Gene expression was normalized against zebrafish gapdh expres-
sion in wild-type embryos. RT-qPCR data were analyzed using the
(DDCt) method (Livak et al., 1998). Student’s t test was performed
using GraphPad Prism 5.0. In all tests, difference was considered
significant if P < 0.001.
Immunofluorescence
Embryos for immunofluorescent detection were processed following
the protocol proposed by (Ungos et al., 2003). Embryos were fixed in
4% paraformaldehyde in PBS (phosphate-buffered saline; Oxoid,
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Basingstoke, Hampshire, UK) overnight at 4°C. They were washed
three times for 5 min in PBTriton (0.1% Triton X-100 Sigma-Aldrich in
PBS) and three times for 1 h in MilliQ water. Embryos were
incubated in block solution (1% DMSO, 5% Goat/Sheep serum
diluted in PBTriton) for 2–3 h. They were then incubated at room
temperature overnight in polyclonal mouse serum primary antibody
(polyclonal IgG rabbit anti-GFP primary antibody; Invitrogen, A11122)
diluted 1:500 in block solution. Embryos were washed in PBTriton
once briefly and three times for 1 h. They were incubated overnight
at 4°C in Alexa Fluor 488 fluorescent anti-rabbit secondary antibody
(polyclonal IgG Alexa Fluor 488 donkey anti-rabbit; Invitrogen,
A21206) diluted 1:200 in block solution. Embryos were then washed
once briefly and three times for 30 min in PBTriton. They were stored
in 50% glycerol for imaging and storage.
Microscopy
Fish were mounted between bridged coverslips in methylcellulose
for live embryos, anesthetized with 0.003% MS222 (Sigma), and in
80% glycerol for fixed embryos. Embryos were photographed using
a Spot digital camera (Leica, Manchester, UK) mounted on an
Eclipse E800 microscope (Nikon UK Limited, Kingston upon
Thames, Surrey, UK) or Axioplan 2 microscope (Zeiss, Cambridge,
UK) with DIC optics using a Spot digital camera mounted on a MZ12
microscope (Leica) with epi-illumination or Nikon sight DS-U1
camera (Nikon UK Limited). To minimize the effects of the
developmental gradient along the body axis, melanocyte counts
were performed on the head only, from the anteriormost region
(forebrain) to the rear of the otic vesicle (posterior hindbrain);
melanocytes were counted only in the region dorsal to the CNS (i.e.,
the developing dorsal stripe).
Dendricity measurement
Dendricity was calculated as R (R = P2/4 pA, where A is the cell area
and P the cell perimeter), and cell perimeter and area were measured
using IMAGEJ software from images of cells taken using Eclipse E800
microscope (Nikon UK Limited).
Ripley’s K function analysis
To quantify and compare melanocyte organization in DMSO-treated
embryos and BIO-treated embryos, the multidistance spatial
cluster analysis, based on Ripley’s K Function, was performed
using R statistical software (using packages SPATSTAT and DPLYR (R
Core Team (2012)). Melanocyte positions were determined on the
dorsal head of ten treated 72 hpf embryos for each conditions
(DMSO and BIO treated) using comparable pictures. x and y
coordinates for each melanocyte’s position were determined using
ImageJ. This data were then used to perform the Ripley’s K
function analysis which allows testing for random partition of the
cells.
A z-test allowed comparison of the two populations for cellular
spatial organization using the results of this analysis; the result was
considered significant if P < 0.01.
Statistics
Data were analyzed by PRISM 3.0 software GRAPHPADPRISM 5.0 using
unpaired t test, a = 0.05%, n = 20, and fd = (x2), with x = number
of embryo tested.
Mathematical modeling
Following the scheme of Figure S4A and indicating the molecular
species with their initials (except Tyrp1, indicated with Ty), we
describe the behavior of the GRN by the following set of ordinary
differential equations:
dZ
dt
¼ gZ B
KB þ B  dZZ
dS
dt
¼
gS
U2AðX1X2 þ X1HÞ þ X2MðU1U2 þ U1HÞ þ X2MU2A
ðU1U2 þ U2A þ U1HÞðX1X2 þ X2M þ X1HÞ
 
 dSS
dM
dt
¼ gM
"
ðC2S þ C1S2Þ eT
ðC12 þ C2S þ C1S2ÞðKT þ eT Þ 
1fMT
ðKT þ T ÞðKM þfMÞ
!
þ
fM eT
ðKT þ eT ÞðKM þfMÞ
#
 dMM
dT
dt
¼ gT KWBWAðtÞ þ KWAWBðtÞ þWAðtÞWBðtÞðKWB þWBðtÞÞðKWA þWAðtÞÞ  dT T
dH
dt
¼ gH M
KM1 þM  dHH
dTy
dt
¼ gTy M
KM2 þM  dTyTy
dD
dt
¼ gD KZM þ KM3Z þMZðKZ þ Z ÞðKM3 þMÞ
KS
KS þ S  dDD
with :
fM ¼MHðM MÞeT ¼ THðT  T Þ
(
;
WAðtÞ ¼WA Hðt  30 hÞ Hðt  15 hÞð ÞGBIO
WBðtÞ ¼WBHðt  30 hÞGBIO

and :HðxÞ¼ 0 x\0
1 x0

;
GBIO¼ 1 untreatedt tSBIO
 
H t tEBIO
 H t tSBIO   BIO-treated

All equations have been derived from the network scheme in
Figure S4A by applying the rules explained in Greenhill et al.
(2011). In addition, here we consider b-catenin/Lef-1 (T) acting in
conjunction with either Sox10 (S) or Mitfa (M) via an AND gate to
activate the production of Mitfa itself. This means that Mitfa
production is activated only when either of the two AND gates
involving T (one with Sox10 and the other with Mitfa) is active.
The AND gate with Sox10 is activated only when the concentra-
tion of T is larger than a given threshold T . A second threshold M
on the concentration of Mitfa is operative also on the self-
activating loop of Mitfa.
The core of the network corresponds to what has already been
modeled in Greenhill et al. (2011) with the addition of Wnt
signaling. Wnt is assumed to have two components WntA (WA in
the equations above) and WntB (WB) both activating transcription
factor b-catenin/Lef-1 (indicated as T in the equations). The binding
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and unbinding dynamics of Wnt is assumed to be fast as compared
to the other network reactions, and therefore, Wnt is assumed to
be equilibrated at any time. The first component WntA is present
only for a transient time between 15 and 30 hpf, while the second
component WntB starts at 30 hpf and remains active throughout
the whole differentiation process (see Figure S4B). When these
two components act together they guarantee specification and
commitment of the melanocytes lineage. If only WntA is present,
then we have specification but no commitment (see Figure S4C),
while if only WntB is present, no specification is observed
(Figure S4D). Notice that this mechanism relies on the presence
of a threshold on the activation of the AND gate between Sox10
and T which prevents the production of Mitfa and therefore the
activation of Mitfa’s feedback loop. In order to simulate the BIO
treatment, we added a correction GBIO to the WA and WB
components, which amounts to a time-linear increase in Wnt
when the BIO treatment is applied between tSBIO and t
E
BIO (times
of start and end of the treatment, respectively) and is one when
there is no BIO treatment. Parameter values for the model are as
follows:
gZ ¼ 0:1 nM=h
gS ¼ 0:3 nM=h
gM ¼ 0:35 nM=h
gT ¼ 1:3 nM=h
gH ¼ 0:3nM=h
gTy ¼ 3:1 nM=h
gD ¼ 0:3nM=h
8>>>><>>>>:
;
dZ ¼ 0:2=h
dS ¼ 0:3=h
dM ¼ 0:05=h
dT ¼ 0:6=h
dH ¼ 0:03=h
dTy ¼ 0:6=h
dD ¼ 0:1=h
8>>>><>>>>:
;
X1 ¼ 1:92 nM
X2 ¼ 1:43 nM
X12 ¼ 1:32 nM
U1 ¼ 2:0nM
U2 ¼ 0:22 nM
U12 ¼ 0:1 nM
KB ¼ 0:175nM
KWA ¼ 0:5nM;
KWB ¼ 0:5 nM
8>>>>>>><>>>>>>:
;
KT ¼ 7:8nM
KM ¼ 0:045 nM
KM1 ¼ 1:0 nM
KM2 ¼ 1:8 nM
KM3 ¼ 1:0 nM
KZ ¼ 6:5 nM
KS ¼ 1:2 nM
8>>>><>>>>:
;
WA ¼ 0:33 nM
WB ¼ 0:25 nM
M ¼ 0:01 nM
T ¼ 0:75 nM
C1 ¼ 5:0=ðnMhÞ2
C2 ¼ 4:5=ðnMhÞ2
C12 ¼ 1:8=ðnMhÞ2
8>>>><>>>>:
These values are chosen in accordance with measured values from
the literature (Eden et al., 2011; Jin and Liao, 1999; Schwanh€ausser
et al., 2011; for Sox10, Jao et al., 2013 for Mitfa) and within similar
ranges as in Greenhill et al. (2011) for those unknown. We have
assumed the same affinity for the two Wnt components and larger
concentration for WA, but the opposite assumption (different affinity
and same concentration) would lead to the same results. A slower
decay rate for Mitfa than the one used in Greenhill et al., 2011
produced a better quantitative agreement with BIO treatment results.
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Supporting information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Ripley’s K function analysis shows signifi-
cant decrease in melanocyte organization in BIO-treated
embryos compared to DMSO-treated embryos at 72 hpf.
Figure S2. Strong expression of a dntcf3 transgene
results in poor melanocyte differentiation.
Figure S3. Ripley’s K function analysis shows signifi-
cant decrease in melanocyte organization when Wnt
signaling is impaired in dntcf3 transgenic embryos at
72 hpf.
Figure S4. (A) Core GRN for melanocyte differentia-
tion activated by Wnt signaling. (B) Schematic of WntA
and WntB signaling. (C, D) Selective failure of specifi-
cation and commitment. (E, F) Simulation of the core
GRN according to the mathematical model (see Meth-
ods).
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